Cigarettes?No, Never.
Marijuanna? No, it’s illegal, well maybe-- What about a mouth spray?
Medical marijuana has often been a topic in the news and on political agendas of a handful of states, but it is difficult to obtain.Anecdotal evidence provides most of our information in the
United States
because laws and wide-spread drug anxiety limit official research.
However, t
he National MS Society has reported on benefits and side effects of marijuana derivatives (specifically THC) to treat spasticity, tremors, and pain.In the society’s officialstatement,a report was cited that cautionssmokingdelivers an uncontrolled dosage where specific compounds hold promise for MS symptoms. But now there isbreaking newsthat might update the official stance.
In January, the F.D.A. approved advanced clinical trials of a marijuana-derived drug called Sativex, which comes in the form of a mouth spray. Sativex has been approved inCanadafor the treatment of neuropathic pain associated with multiple sclerosis, and it is available by prescription (though not yet fully licensed) inSpainand
Britain
. According to GW Pharmaceuticals, the British company that makes the drug, more than 1,500 patients in those three countries are usingSativexto alleviate pain, muscle spasticity and other serious problems.
technorati tags:ms,multiplesclerosis,healthcare,medicalresearch,medicalmarijuana,sativex
Cigarettes?No, Never.
Marijuanna? No, it’s illegal, well maybe-- What about a mouth spray?
Medical marijuana has often been a topic in the news and on political agendas of a handful of states, but it is difficult to obtain.Anecdotal evidence provides most of our information in the
United States
because laws and wide-spread drug anxiety limit official research.
However, t he National MS Society has reported on benefits and side effects of marijuana derivatives (specifically THC) to treat spasticity, tremors, and pain.In the society’s officialstatement,a report was cited that cautionssmokingdelivers an uncontrolled dosage where specific compounds hold promise for MS symptoms. But now there isbreaking newsthat might update the official stance.
In January, the F.D.A. approved advanced clinical trials of a marijuana-derived drug called Sativex, which comes in the form of a mouth spray. Sativex has been approved inCanada for the treatment of neuropathic pain associated with multiple sclerosis, and it is available by prescription (though not yet fully licensed) inSpain and
Britain
. According to GW Pharmaceuticals, the British company that makes the drug, more than 1,500 patients in those three countries are usingSativexto alleviate pain, muscle spasticity and other serious problems.
technorati tags:ms,multiplesclerosis,healthcare,medicalresearch,medicalmarijuana,sativex